{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:52Z","timestamp":1786118932919,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceutica","doi-asserted-by":"publisher","award":["5-63\/2015"],"award-info":[{"award-number":["5-63\/2015"]}],"id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jad.2026.121415","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T08:01:50Z","timestamp":1771315310000},"page":"121415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Factors associated with long-term hypnotics use in depression"],"prefix":"10.1016","volume":"403","author":[{"given":"Adam","family":"Nygren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Tiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Gembert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Taipale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Reutfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.121415_bb0005","series-title":"Practice Guideline for the Treatment of Patients With Major Depressive Disorder","author":"American Psychiatric Association","year":"2010"},{"key":"10.1016\/j.jad.2026.121415_bb0010","series-title":"Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts","author":"American Psychological Association","year":"2019"},{"key":"10.1016\/j.jad.2026.121415_bb0015","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/pds.2104","article-title":"Long-term use of zopiclone, zolpidem and zaleplon among Danish elderly and the association with sociodemographic factors and use of other drugs","volume":"20","author":"Andersen","year":"2011","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jad.2026.121415_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use: a meta-analysis","volume":"18","author":"Barker","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2026.121415_bb0025","article-title":"Clinical guidelines for the management of depression with specific comorbid psychiatric conditions French recommendations from experts (the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental)","volume":"19","author":"Bennabi","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2026.121415_bb0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000536063","article-title":"Psychological treatment of comorbid insomnia and depression: a double-blind randomized placebo-controlled trial","volume":"93","author":"Blom","year":"2024","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2026.121415_bb0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-046916","article-title":"Risk of long-term benzodiazepine and Z-drug use following the first prescription among community-dwelling adults with anxiety\/mood and sleep disorders: a retrospective cohort study","volume":"11","author":"Brandt","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jad.2026.121415_bb0040","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamapsychiatry.2017.1273","article-title":"Simultaneous antidepressant and benzodiazepine new use and subsequent long-term benzodiazepine use in adults with depression, United States, 2001-2014","volume":"74","author":"Bushnell","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.121415_bb0045","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s00198-018-4564-z","article-title":"Antihistamine use and the risk of injurious falls or fracture in elderly patients: a systematic review and meta-analysis","volume":"29","author":"Cho","year":"2018","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.jad.2026.121415_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/mpr.1998","article-title":"New users of anxiolytics and sedatives in Sweden\u2014drug type, doses, prescribers\u2019 characteristics, and psychiatric comorbidity in more than 750,000 patients","volume":"33","author":"Dahl\u00e9n","year":"2024","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.121415_bb0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.genhosppsych.2019.11.008","article-title":"Long-term use of hypnotics: analysis of trends and risk factors","volume":"62","author":"Enomoto","year":"2020","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2026.121415_bb0060","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jad.2024.09.017","article-title":"Cognitive behavioral therapy for insomnia to treat major depressive disorder with comorbid insomnia: a systematic review and meta-analysis","volume":"367","author":"Furukawa","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121415_bb0065","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3390\/neurolint15010031","article-title":"Chronic administration of melatonin: physiological and clinical considerations","volume":"15","author":"Givler","year":"2023","journal-title":"Neurol. Int."},{"key":"10.1016\/j.jad.2026.121415_bb0070","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jpsychires.2024.07.051","article-title":"Factors associated with the long-term use of benzodiazepine receptor agonists as hypnotics among patients with major depressive disorder and comorbid insomnia","volume":"178","author":"Habukawa","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.121415_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236434","article-title":"A register-based approach to identifying treatment-resistant depression-comparison with clinical definitions","volume":"15","author":"H\u00e4gg","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2026.121415_bb0080","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/da.20524","article-title":"Treatment of major depressive disorder in the Finnish general population","volume":"26","author":"H\u00e4m\u00e4l\u00e4inen","year":"2009","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2026.121415_bb0085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpsychires.2017.11.012","article-title":"What can predict and prevent the long-term use of benzodiazepines?","volume":"97","author":"Hata","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.121415_bb0090","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13930","article-title":"Insomnia\u2014a risk factor for mental disorders","volume":"32","author":"Hertenstein","year":"2023","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.jad.2026.121415_bb0095","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00228-023-03515-2","article-title":"Factors associated with long-term benzodiazepine and Z-drug use across the lifespan and 5-year temporal trajectories among incident users: a Swedish nationwide register-based study","volume":"79","author":"Isomura","year":"2023","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2026.121415_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-019-2222-4","article-title":"The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study","volume":"19","author":"Jaffe","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2026.121415_bb0105","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jagp.2016.03.009","article-title":"Depression and depression treatment in a population-based study of individuals over 60 years old without dementia","volume":"24","author":"Karlsson","year":"2016","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2026.121415_bb0110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00406-016-0706-5","article-title":"Efficacy and tolerability of Z-drug adjunction to antidepressant treatment for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials","volume":"267","author":"Kishi","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2026.121415_bb0115","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","article-title":"Long-term use of benzodiazepines: definitions, prevalence and usage patterns - a systematic review of register-based studies","volume":"30","author":"Kurko","year":"2015","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2026.121415_bb0120","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/07067437241245384","volume":"69","author":"Lam","year":"2024","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jad.2026.121415_bb0125","article-title":"The therapeutic effect of exogenous melatonin on depressive symptoms: a systematic review and meta-analysis","volume":"13","author":"Li","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2026.121415_bb0130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jama.2021.23652","article-title":"Trends in use of melatonin supplements among US adults, 1999-2018","volume":"327","author":"Li","year":"2022","journal-title":"Jama"},{"key":"10.1016\/j.jad.2026.121415_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jad.2026.121415_bb0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0004867420979353","article-title":"The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders","volume":"55","author":"Malhi","year":"2021","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121415_bb0145","series-title":"Concise Dictionary of Pharmacological Agents: Properties and Synonyms","author":"Morton","year":"2012"},{"key":"10.1016\/j.jad.2026.121415_bb0150","series-title":"Depression in Adults: Treatment and Management (Update)","author":"National Institute for Health and Care Excellence","year":"2022"},{"issue":"1","key":"10.1016\/j.jad.2026.121415_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.14267","article-title":"Trends in hypnotic drug use in depression 2007-2017: a Swedish population-based study","volume":"34","author":"Nygren","year":"2024","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.jad.2026.121415_bb0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/smrv.2002.0186","article-title":"Epidemiology of insomnia: what we know and what we still need to learn","volume":"6","author":"Ohayon","year":"2002","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.jad.2026.121415_bb0165","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1111\/bcp.14819","article-title":"Antihistamine-related deaths in England: are the high safety profiles of antihistamines leading to their unsafe use?","volume":"87","author":"Oyekan","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2026.121415_bb0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00406-018-0966-3","article-title":"Use of benzodiazepines and z-drugs not compliant with guidelines and associated factors: a population-based study","volume":"270","author":"Panes","year":"2020","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2026.121415_bb0175","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/JCP.0b013e318217b4c4","article-title":"Benzodiazepines and adequacy of initial antidepressant treatment for depression","volume":"31","author":"Pfeiffer","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.121415_bb0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7326\/M15-2175","article-title":"Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians","volume":"165","author":"Qaseem","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jad.2026.121415_bb0185","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/M22-2056","article-title":"Nonpharmacologic and pharmacologic treatments of adults in the acute phase of major depressive disorder: a living clinical guideline from the American College of Physicians","volume":"176","author":"Qaseem","year":"2023","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jad.2026.121415_bb0190","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41386-019-0411-y","article-title":"Sleep, insomnia, and depression","volume":"45","author":"Riemann","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2026.121415_bb0195","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.14035","article-title":"The European insomnia guideline: an update on the diagnosis and treatment of insomnia 2023","volume":"32","author":"Riemann","year":"2023","journal-title":"J. Sleep Res."},{"issue":"10","key":"10.1016\/j.jad.2026.121415_bb0200","first-page":"1493","article-title":"Sedative drug-use in Denmark, 2000 to 2019: a nationwide drug utilization study","volume":"58","author":"Rosenqvist","year":"2022","journal-title":"Soc. Psychiatry Psychiatr."},{"issue":"3","key":"10.1016\/j.jad.2026.121415_bb0205","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1176\/appi.ajp.20230075","article-title":"Long-term use of benzodiazepines and benzodiazepine-related drugs: a register-based Danish cohort study on determinants and risk of dose escalation","volume":"181","author":"Rosenqvist","year":"2023","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121415_bb0210","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1007\/s00213-017-4634-5","article-title":"Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data","volume":"234","author":"Sakurai","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2026.121415_bb0215","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/ijnp\/pyz007","article-title":"An insight into Z-drug abuse and dependence: an examination of reports to the European medicines agency database of suspected adverse drug reactions","volume":"22","author":"Schifano","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.121415_bb0220","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1017\/S1092852900029266","article-title":"Insomnia in patients with depression: a STAR*D report","volume":"15","author":"Sunderajan","year":"2010","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2026.121415_bb0225","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.19029","article-title":"Incidence of and characteristics associated with long-term benzodiazepine use in Finland","volume":"3","author":"Taipale","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jad.2026.121415_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113753","article-title":"Factors associated with long-term use of hypnotics among patients with chronic insomnia","volume":"9","author":"Takaesu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2026.121415_bb0235","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029641","article-title":"Factors associated with long-term prescription of benzodiazepine: a retrospective cohort study using a health insurance database in Japan","volume":"9","author":"Takano","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jad.2026.121415_bb0240","series-title":"National Prescribed Drug Register","author":"The National Board of Health and Welfare","year":"2022"},{"key":"10.1016\/j.jad.2026.121415_bb0245","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jad.2026.121415_bb0250","series-title":"Definition and General Considerations","author":"WHO Collaborating Centre for Drug Statistics Methodology","year":"2025"},{"key":"10.1016\/j.jad.2026.121415_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13101485","article-title":"Benzodiazepine use and the risk of dementia in the elderly population: an umbrella review of meta-analyses","volume":"13","author":"Wu","year":"2023","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.jad.2026.121415_bb0260","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00198-013-2446-y","article-title":"Association between use of benzodiazepines and risk of fractures: a meta-analysis","volume":"25","author":"Xing","year":"2014","journal-title":"Osteoporos. Int."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726002661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726002661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:58:03Z","timestamp":1786035483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726002661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":52,"alternative-id":["S0165032726002661"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.121415","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with long-term hypnotics use in depression","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.121415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121415"}}